| 标题 |
Abstract 4369238: THRV-1268, a potent and selective serum and glucocorticoid regulated kinase (SGK1) inhibitor, improves adverse cardiac remodeling better than Jardiance® (empagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor in heart failure |
| 网址 | |
| DOI | |
| 其它 |
期刊:Circulation 作者:Sabindra Pradhananga; William Salvail; Eric Campeau; Dinesh Srinivasan; Marc Vidal; et al 出版日期:2025-11-04 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)